Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is implantation of a Pacemaker at 30 days for occurrence of a high-grade conduction disorder per- or post-procedure (yes/no)


Clinical Trial Description

The main objective is to assess the predictive value of the pre-TAVI infrahelic conduction time interval (infraheal conduction time measured before percutaneous aortic valve implantation) on the risk of Pacemaker implantation at 30 days post-TAVI, in patients with right bundle branch block prior to surgery. The aim of the study is to identify a pre-interventional marker of the risk of rhythmological complication after the TAVI procedure (Transcatheter Aortic Valve Implantation), in order to better anticipate it. This is an interventional, prospective, longitudinal (follow-up: 12 months), multicenter (4 centers) study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05714579
Study type Interventional
Source GCS Ramsay Santé pour l'Enseignement et la Recherche
Contact Oualid ZOUAGHI, MD
Phone 666687365
Email ozouaghi@cardiopole.fr
Status Recruiting
Phase N/A
Start date May 30, 2023
Completion date June 2026